Title of article
Pernicious anemia following COVID-19 vaccination: A report of two cases
Author/Authors
Soltani ، Hamidreza Deparement of Rheumatology - Shahid Sadoughi University of Medical Sciences , Taghizade ، Saeb Department of Biology - Medical Biotechnology Research Center - Islamic Azad University, Ashkezar Branch , Sadeghi ، Abdolrahim Department of Radiology - Shahid Sadoughi University of Medical Sciences , Farahat ، Ali Department of Hematology and Oncology - Shahid Sadoughi University of Medical Sciences , Owlia ، Mohammad Bagher Deparement of Rheumatology - Shahid Sadoughi University of Medical Sciences
From page
220
To page
223
Abstract
Since December 2019 and the global epidemic of COVID-19 different countries have focused on vaccines, and one of the inactivated produced vaccines was the Sinopharm COVID-19 vaccine. Some side effects of this vaccine were reported previously, including pain at the vaccination site, fatigue, lethargy, headache, and tenderness, which were more prevalent among individuals 49 years old. Herein, we reported two patients aged 45 and 51 years old. Both patients have different signs and symptoms after receiving the second dose of the vaccine. None had a history of chronic disease. On examination and following labs and other diagnostic investigations, we found megaloblastic anemia due to atrophic gastritis and low intrinsic factor. These cases showed an autoimmune side effect of the Sinopharm COVID-19 vaccine that was previously reported with an exact mechanism but other features called Covid Arm, Guillain-BarrxE9; syndrome, and thrombocytopenia. The mechanism of this reaction is unclear yet.
Keywords
COVID , 19 , Vaccination , Pernicious anemia
Journal title
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
Journal title
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
Record number
2751680
Link To Document